![Jean Nordström](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean Nordström
Vorstandsvorsitzender bei Labiana Life Sciences Services SL
Ursprung des Netzwerks ersten Grades von Jean Nordström
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Sixera Pharma AB
![]() Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden.
3
| Holding Company | Pharmaceuticals: Generic | 3 |
Labiana Life Sciences Services SL
![]() Labiana Life Sciences Services SL Pharmaceuticals: MajorHealth Technology Labiana Life Sciences Services SL operates as a holding company with an interest in specializing in the manufacture of pharmacological products for veterinary use. The firm's products include animal health and livestock hygiene. Its services include contract laboratory, manufacturing, regulatory, and contract distribution services. The company was founded in 1958 and is headquartered in Terrassa, Spain.
1
| Private Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jean Nordström
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Athera Biotechnologies AB
![]() Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Industrifonden
![]() Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Director of Investments | |
Labiana Life Sciences SA
![]() Labiana Life Sciences SA Miscellaneous Commercial ServicesCommercial Services Labiana Life Sciences SA provides technical outsourcing services for the life sciences sector. It offers contract laboratory, manufacturing, and regulatory services, including project management, process & analytical development, logistics, and packaging. The company has two operating facilities in Barberà del Vallès and Terrassa. Labiana Life Sciences was founded in 1958 and is headquartered in Terrassa, Spain. | Miscellaneous Commercial Services | President | |
Karolinska Development AB (Private Equity)
![]() Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Private Equity Investor | |
FLERIE INVEST AB | Pharmaceuticals: Major | Director/Board Member | |
Arexis AB
![]() Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
University of Lund | College/University | Doctorate Degree | |
Umea Universitet | College/University | Doctorate Degree | |
OxThera AB
![]() OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Beactica Therapeutics AB
![]() Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Medical Distributors | Director/Board Member | |
Kabigen AB | Corporate Officer/Principal | ||
AddBIO AB
![]() AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Biotechnology | Director/Board Member | |
Medtentia International Ltd. Oy
![]() Medtentia International Ltd. Oy Medical SpecialtiesHealth Technology Medtentia International Ltd. Oy is a holding company that develops solutions for mitral valve repair based on its proprietary helix ring concept. It is a medical technology company that creates solutions for cardiac interventions. It provides proprietary, helix-shaped products to address the unmet need in cardiac surgery. The company was founded by Dan Mogren and Olli U. Keränen in 2002 by Olli Keränen and is headquartered in Espoo, Finland. | Medical Specialties | Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Corporate Officer/Principal | |
Symbicom AB | Corporate Officer/Principal | ||
InDex Diagnostics AB
![]() InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
XINTELA AB | Biotechnology | Director/Board Member | |
Cormorant Pharmaceuticals AB
![]() Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Chief Executive Officer | |
Beacon Software, Inc. /NY/
![]() Beacon Software, Inc. /NY/ Packaged SoftwareTechnology Services Beacon Software, Inc. is a software development management company based in New York, NY. Beacon Software, Inc. offers AI-powered assurance to help prevent software project failures. The company's platform provides instant project visibility, precise delivery and tracking, and real-time insights delivered before bottlenecks start. The CEO of the company is Jim Anderson. | Packaged Software | Director/Board Member | |
Atrogi AB
![]() Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
InDex Pharmaceuticals AB
![]() InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Ignitus AB | Chairman | ||
Cinclus Pharma AG
![]() Cinclus Pharma AG BiotechnologyHealth Technology Cinclus Pharma AG is a Swiss Swedish pharmaceutical company founded in 2011. Cinclus Pharma is based in Basel, Switzerland. The private company is focused on bringing relief to people suffering from gastric acid related diseases, particularly gastroesophageal reflux disease (GERD). Cinclus Pharma's clinical stage drug candidate, linaprazan glurate, is a new approach to managing GERD and is showing promising results in acid control and lowering the cmax-value. The company was founded by experts in the field of GERD treatment with extensive experience from Astra and Astra Zeneca. | Biotechnology | Director/Board Member | |
Chateau Holding AB | Director/Board Member | ||
Gesynta Pharma AB
![]() Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Nylof Holding AB
![]() Nylof Holding AB Investment Banks/BrokersFinance Nylof Holding AB provides security brokerage services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Malmö Industrifinans AB
![]() Malmö Industrifinans AB Investment Banks/BrokersFinance Malmö Industrifinans AB is a Swedish company that engages in buying and selling of shares. | Investment Banks/Brokers | Director/Board Member | |
Cinclus Pharma Holding AB
![]() Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Biotechnology | Founder | |
Amarna Therapeutics BV
![]() Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
Targinta AB
![]() Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Director/Board Member | |
Cavis Technologies AB | Director/Board Member | ||
QureTech Bio AB | Director/Board Member | ||
Buzzard Pharmaceuticals AB
![]() Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Chief Executive Officer | |
Evident Life Försäkring AB | Director/Board Member | ||
Cordivest AB | Chief Executive Officer | ||
MetaCurUm Biotech AB | Chief Executive Officer | ||
Strike Pharma AB
![]() Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Amarna Holding BV | Director/Board Member | ||
Saare Consulting AB | Director/Board Member |
Statistik
International
Schweden | 45 |
Niederlande | 3 |
Spanien | 2 |
Finnland | 2 |
Vereinigte Staaten | 2 |
Sektoral
Health Technology | 22 |
Finance | 8 |
Commercial Services | 7 |
Consumer Services | 3 |
Distribution Services | 2 |
Operativ
Director/Board Member | 41 |
Corporate Officer/Principal | 7 |
Chief Executive Officer | 6 |
Independent Dir/Board Member | 5 |
Chairman | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Jean Nordström
- Unternehmensverbindungen